Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H (2014) Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol 2014:437971
Article
Google Scholar
Paska AV, Hudler P (2015) Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb) 25:161–176
Article
Google Scholar
Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K et al (2012) Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol 13:R97
Article
CAS
Google Scholar
Marzese DM, Hoon DS (2015) Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer. Expert Rev Mol Diagn 15:647–664
Article
CAS
Google Scholar
Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA et al (2011) Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation associated pathology in early-onset breast cancer. Cancer Prev Res 4:23–33
Article
CAS
Google Scholar
Cai F, Ge I, Wang M, Biskup E, Lin X, Zhong X (2014) Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells. Tumour Biol 35:3839–3844
Article
CAS
Google Scholar
Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103:12405–12410
Article
CAS
Google Scholar
Moroishi T, Hansen CG, Guan KL (2015) The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15:73–79
Article
CAS
Google Scholar
Totaro A, Panciera T, Piccolo S (2018) YAP/TAZ upstream signals and downstream responses. Nat Cell Biol 20:888–899
Article
CAS
Google Scholar
Hansen CG, Moroishi T, Guan KL (2015) YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol 25:499–513
Article
CAS
Google Scholar
Greene FL, Page DL, Fleming ID (eds) (2002) AJCC cancer staging manual, 6th edn, p 435
Google Scholar
Gown AM (2008) Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 21:S8–S15
Article
CAS
Google Scholar
Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821–9826
Article
CAS
Google Scholar
Ramadan RA, Zaki MA, Awad AM, El-Ghalid LA (2015) Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis. Genet Test Mol Biomarkers 19:399–404
Article
CAS
Google Scholar
Real SAS, Parveen F, Rehman AU, Khan MA, Deo SVS, Shukla NK et al (2018) Aberrant promoter methylation of YAP gene and its subsequent downregulation in Indian breast cancer patients. BMC Cancer 18:711
Article
Google Scholar
Zhao B, Tumaneng K, Guan KL (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13:877–883
Article
CAS
Google Scholar
Tufail R, Jorda M, Zhao W, Reis I, Nawaz Z (2012) Loss of yes-associated protein (YAP) expression is associated with estrogen and progesterone receptor negativity in invasive breast carcinomas. Breast Cancer Res Treat 131:743–750
Article
CAS
Google Scholar
Wang X, Su L, Ou Q (2012) Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. Eur J Cancer 48:1227–1234
Article
CAS
Google Scholar
Kim SK, Jung WH, Koo JS (2014) Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer. Int J Clin Exp Pathol 7:3224–3234
PubMed
PubMed Central
Google Scholar
Kim HM, Jung WH, Koo JS (2015) Expression of yes-associated protein (YAP) in metastatic breast cancer. Int J Clin Exp Pathol 8:11248–11257
CAS
PubMed
PubMed Central
Google Scholar
Wang T, Mao B, Cheng C, Zou Z, Gao J, Yang Y et al (1864) YAP promotes breast cancer metastasis by repressing growth differentiation factor-15. Biochim Biophys Acta 2018:1744–1753
Google Scholar
Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 101:1279–1285
Article
CAS
Google Scholar
Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M et al (2011) YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32:389–398
Article
CAS
Google Scholar
Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB et al (2011) The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 30:2810–2822
Article
CAS
Google Scholar
Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Harada T et al (2008) Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15:1752–1759
Article
CAS
Google Scholar
Zhi X, Zhao D, Zhou Z, Liu R, Chen C (2012) YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am J Pathol 180:2452–2461
Article
CAS
Google Scholar
Shen J, Cao B, Wang Y, Ma C, Zeng Z, Liu L et al (2018) Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer. J Exp Clin Cancer Res 37:175
Article
Google Scholar
Kim B, Myung SJ (2018) Clinical implications of the Hippo-YAP pathway in multiple cancer contexts. BMB Rep 51:119–125
Article
CAS
Google Scholar
Cao L, Sun PL, Yao M, Jia M, Gao H (2017) Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues. Hum Pathol 68:166–174
Article
CAS
Google Scholar
Guo L, Teng L (2015) YAP/TAZ for cancer therapy: opportunities and challenges (review). Int J Oncol 46:1444–1452
Article
CAS
Google Scholar
Song R, Gu D, Zhang L, Zhang X, Yu B, Liu B et al (2018 Aug 3) Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer. Mol Carcinog. https://doi.org/10.1002/mc.22883
Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA et al (2012) Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 26:1300–1305
Article
CAS
Google Scholar
Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S et al (2014) Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol 16:357–366
Article
CAS
Google Scholar
Gronich N, Rennert G (2013) Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol 10:625–642
Article
CAS
Google Scholar